Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial
Abstract Background Previous studies have explored the anti-diabetic effects of Cinnamomum cassia extract in vivo and in vitro. However, there are no studies at present exploring the effects of the indigenous species of Sri Lankan cinnamon (Cinnamomum zeylanicum) in patients with diabetes mellitus....
Main Authors: | Priyanga Ranasinghe, Priyadarshani Galappaththy, Godwin Roger Constantine, Ranil Jayawardena, Hasitha Dhananjaya Weeratunga, Sirimal Premakumara, Prasad Katulanda |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-09-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-017-2192-0 |
Similar Items
-
Evaluation of pharmacodynamic properties and safety of Cinnamomum zeylanicum (Ceylon cinnamon) in healthy adults: a phase I clinical trial
by: Priyanga Ranasinghe, et al.
Published: (2017-12-01) -
“Ceylon cinnamon”: Much more than just a spice
by: Lalith Suriyagoda, et al.
Published: (2021-07-01) -
Anti-inflammatory, cytotoxicity and antilipidemic properties: novel bioactivities of true cinnamon (Cinnamomum zeylanicum Blume) leaf
by: Walimuni Prabhashini Kaushalya Mendis Abeysekera, et al.
Published: (2022-10-01) -
Cinnamomum zeylanicum Blume (Ceylon cinnamon) bark extract attenuates doxorubicin induced cardiotoxicity in Wistar rats
by: Jayasinghe Arachchige Nirosha Sandamali, et al.
Published: (2021-08-01) -
Cognitive- and memory-enhancing activity of Cinnamon (Cinnamomum zeylanicum) aqueous extract in lead acetate-exposed rats
by: Adaze Bijou Enogieru, et al.
Published: (2024-09-01)